Abstract
Alsace, in particular Haut-Rhin, is one of the main clusters of COVID-19 in France. There has been a shortage of essential supplies in the area, especially alcohol-based hand sanitizer. In this context, and in accordance with the decree dated March 6, 2020, our hospital management team asked us to start local production of alcohol-based handrub. This was a real challenge: In one week, we had to implement the production of handrub to meet the needs of a 1,400-bed hospital. The production had to comply with the French preparation guidelines and take place on specific premises, with qualified and calibrated equipment, by qualified staff, under the supervision of a pharmacist. The other big challenge we faced was the supply of pharmaceutical raw and packaging materials. During this particular critical period, all suppliers were out of stock. Here, we describe the organizational set-up and the decisions made, e. g., to use technical-grade ethanol before the publication of the decrees dated March 13 and March 23, 2020.
Introduction
Alsace, in particular Haut-Rhin, is one of the main clusters of the COVID-19 pandemic in France [1]. There is a substantial shortage of essential and basic personal protective equipment and supplies, in particular of alcohol-based hand sanitizer. According to management, our hospital pharmacy implemented the temporary local production of alcohol-based handrub to avoid running out of stock and to fight against the spread of SARS-CoV-2 in the hospital. This was a real challenge: In one week, we had to implement the production of handrub to meet the needs of a 1,400-bed hospital. Here, we describe the organizational set-up and the decisions made to start production as soon as possible.
Chronology of a tense week
March 6: Due to the risk of a national shortage of alcohol-based hand sanitizers and the contagious nature of SARS-CoV-2, the French reporternment published a decree authorizing all pharmacists to prepare their own alcohol-based handrub in accordance with the World Health Organization (WHO) guidelines using pharmaceutical-grade raw material [2], [3].
March 9: The stock of alcohol-based hand sanitizers in the hospital was rated at one week. No delivery had been planned. All main pharmaceutical suppliers were asked about the availability of raw material with pharmaceutical-grade ethanol, glycerin, and hydrogen peroxide. Late in the morning, all of the main pharmaceutical suppliers reported being out of stock of all concentrations of pharmaceutical-grade ethanol. Pharmaceutical-grade glycerin and hydrogen peroxide were available in sufficient quantity.
March 10: Technical-grade ethanol was still available from laboratory suppliers. A large order of 1,000 L was placed. Packaging materials were also unavailable and therefore we organized the recovery of empty bottles within the hospital.
March 11: Considering the state of emergency, a critical request for preparation of handrub from technical-grade ethanol was sent to the Regional Health Agency Grand-Est. At this time, the stock of alcohol-based hand sanitizers in the hospital was rated at three days. Delivery was not guaranteed with the main supplier reporting a six week delay.
March 12: The Regional Health Agency Grand-Est authorized us to use technical-grade ethanol. The first two batches were produced in our usual preparation room. At the same time, a new preparation room was fitted out in the old quality control laboratory located close to the storage room for flammable products.
March 13: The production line was implemented and four more batches of handrub were prepared.
March 14: Publication of the decree dated March 13, 2020, relaxed the rules concerning the raw materials that could be used for these preparations [4].
March 16: Production was now fully operational with 12 batches of 5 L per day corresponding to 300 L per week. Normally, this is the weekly consumption at our hospital but this increased to 500 L during the COVID-19 pandemic alongside the growing needs of the hospital staff. Finally, the hospital received 600 L of industrial alcohol-based hand sanitizers. The production carried out by the hospital pharmacy during this week will constitute a buffer stock.
Why use technical-grade ethanol?
First, the exceptional context should be taken into consideration. A shortage of alcohol-based hand sanitizer was and continues to be a reality everywhere in France. Haut-Rhin was hit hard by the COVID-19 pandemic and thus continuity in the supply of alcohol-based hand sanitizer was vital [1].
Although the decree of March 6, only granted use of pharmaceutical-grade raw material, alcohol-based hand sanitizer is a biocide product not a drug [2]. Biocide products fall under the European regulations of May 22, 2012, which do not recommend the use of pharmaceutical-grade ethanol but a high-quality ethanol supplied by a producer listed on the website of the European Chemicals Agency [5], [6]. The decree dated March 13 took this into account and the decree dated March 23, broadened the use to agricultural and natural ethanol [4], [7].
Finally, analysis of the technical-grade ethanol certificate showed specifications that are very close to those of the European Pharmacopoeia (Table 1) [8], [9]. However, we should point out the absence of information on benzene quantification, miscibility, and Iodoform testing.
Comparison between the European Pharmacopoeia requirements and the certificate of analysis of technical-grade ethanol 96° used [8], [9].
European Pharmacopoeia specifications | Ethanol 96°, Cristalco®, FranceAlcools® Technical grade specifications (Testing procedure) | |
---|---|---|
Organoleptic characteristic | Clear, colorless liquid, volatility | Clear, colorless liquid (OIV method for alcoholic beverage analysis) Hazen coloration < 3 (NF T20-605/UV Spectro) Smell (Internal method) |
Alcohol strength at 20 °C | Between 95.1 and 96.9% v/v | Limits > 96.00 % v/v (OIV method for alcoholic beverage analysis) |
Identification | 1st method: A (Density) and B (Infrared spectrometry) 2nd method: A (Density), C (Permanganate test) and D (Iodoform test) | Density and permanganate test (OIV method for alcoholic beverage analysis) |
Miscibility | Water Methylene chloride | Not carried out |
Acidity | Phenolphthalein test (30 ppm acetic acid) | <1 g acetic acid/hL Pure Alcohol (PA) (OIV method for alcoholic beverage analysis) |
Density | Between 0.805 and 0.812 | Between 0.805 and 0.812 (OIV method for alcoholic beverage analysis) |
UV Absorption | Steadily curve | Steadily curve UV absorption 220 nm (1 cm cell) = max 0.3 UV absorption 230 nm (1 cm cell) = max 0.18 UV absorption 240 nm (1 cm cell) = max 0.08 UV absorption 270 nm (1 cm cell) = max 0.02 (OIV method for alcoholic beverage analysis) |
UV absorption 240 nm (5 cm cell) = max 0.4 | ||
UV absorption between 250 and 260 nm (5 cm cell) = max 0.3 | ||
UV absorption between 270 and 340 nm (5 cm cell) = max 0.1 | ||
Impurities | Methanol < 200 ppm (v/v) Acetaldehyde and acetal < 10 ppm (v/v) of acetaldehyde Benzene < 2 ppm (v/v) Total other impurities < 300 ppm (v/v) | Methanol < 2.5 g/hL PA |
Total aldehydes < 0.5 g acetaldehyde/hL PA | ||
Esters < 1.3 g ethyl acetate/hL PA | ||
High alcohols < 0.5 g methyl2propanol1/hL PA | ||
Furfural (Not detectable) | ||
Ammonia and nitro basis <0.1 g nitrogen/hL PA | ||
(OIV method for alcoholic beverage analysis) | ||
Dry extract | Max 25 ppm (m/v) | <1.5 g/hL PA (OIV method for alcoholic beverage analysis) |
Organizational set-up
Production depends on the resources and materials that are locally available as well as on reporternment regulations. Thus, our production had to comply with the French preparation guidelines and take place on specific premises, with qualified and calibrated equipment, by qualified staff, under the supervision of a pharmacist [10]. The organizational set-up that was implemented involved many employees and was only made possible by their cooperation. Therefore a protocol was written in order to coordinate the whole team (Table 2).
Procedure for alcohol-based handrub production.
Who? | Where? | How? | |
---|---|---|---|
Recovery of empty dirty bottles | |||
Caregiver | Pharmacy |
| |
Routing circuit between pharmacy and sterilization | |||
Sterilization Staff | Pharmacy |
| |
Label removal, cleaning, and disinfection process for reusable handrub bottles label removal and washing procedure | |||
Sterilization Staff | Sterilization |
| |
Preparation of a 5-L antiseptic topical solution containing ethanol 80% (v/v) | |||
Pharmacy technician: 2 preparers 1 controller | Preparation room | Formulation 1:
| Formulation 2:
|
Step by step preparation:
| |||
Label![]() | Back label![]() | ||
Quarantine | |||
Pharmacy technician | Alcohol storage room |
| |
Validation | |||
Pharmacist | Alcohol storage room |
| |
Routing circuit between pharmacy to central store | |||
worker | Pharmacy |
|
Owing to shortages in the supply of packaging material, we organized the recycling of empty bottles. The cleaning procedure was tested on high density polyethylene (HDPE), low density polyethylene (LDPE), and polyethylene terephthalate (PETE) bottles. Only LDPE and HDPE were suitable for the automated cleaning and disinfecting process (Table 2) and could be recycled.
Before production began, all raw materials and certificates of analysis were checked in order to ensure the quality of the products. Every preparation step was double-checked by a third party, as recommended in the French preparation guidelines [10].
As recommended by the WHO and the Regional Health Agency, we performed a pre-procedural and post-procedural analysis of the alcohol concentration with calibrated alcohol meters to guarantee the titration of the alcohol. The accepted limits were fixed to ±5% of the target concentration. We made the necessary adjustments in volume to obtain the final recommended concentration (75–85% for ethanol). The solution was then divided and placed into its final containers. Conditioning alcohol-based handrubs were placed in quarantine for 72 h before use: This allows any spores present in the alcohol or bottles to be destroyed [3].
Conclusion
With the COVID-19 pandemic evolving rapidly, the current health crisis required everyone to make quick but thoughtful decisions. In order to release our first batches of alcohol-based handrub as soon as possible, we had to precede the publication of the decree dated March 13; we started the preparation of alcohol-based handrub from the technical-grade ethanol on March 11 [4]. This decision was discussed on the basis of the European regulations on biocides and it was authorized by the regional health agency [5]. In the same way, the difficulties to procure packaging material led us to recycle empty LDPE and HDPE bottles. This decision was validated after testing the automated cleaning and disinfecting process in collaboration with the sterilization unit.
After two weeks and with collaboration of many support departments at the hospital, 600 L of alcohol-based handrub was produced and provided to different units in our hospital.
Research funding: None declared.
Author contributions: All authors have accepted responsibility for the entire content of this manuscript and approved its submission.
Conflict of interest: The authors state no conflict of interest. All authors have read the journal’s Publication ethics and publication malpractice statement available on the journal’s website and hereby confirm that they comply with all its parts applicable to the present scientific work.
References
1. Sante publique France. New Coronavirus infection (SARS-CoV-2), COVID-19, France and World-Key data on 03/26/2020 at 2 p.m. – Public Health France stopped. Available from: https://www.santepubliquefrance.fr/maladies-et-traumatismes/maladies-et-infections-respiratoires/infection-a-coronavirus/articles/infection-au-nouveau-coronavirus-sars-cov-2-covid-19-france-et-monde [Accessed 27 Mar 2020].Search in Google Scholar
2. Decree dated March 6, 2020: various measures to control the spread of the COVID-19 virus; Official Journal of the French Republic n°0057 dated March 7, 2020. Available from: https://www.legifrance.gouv.fr/eli/arrete/2020/3/6/SSAZ2006830A/jo/texte [Accessed 27 Mar 2020].Search in Google Scholar
3. World Health Organization. WHO-recommended handrub formulations. WHO guidelines on hand hygiene in health care – first global patient safety challenge clean care is safer care. Geneva: World Health Organization; 2009.Search in Google Scholar
4. Decree dated March 13, 2020: authorizing by derogation the temporary availability on the market and the use of certain alcohol-based hand sanitizer; Official Journal of the French Republic n°0063 dated March 14, 2020. Available from: https://www.legifrance.gouv.fr/eli/arrete/2020/3/13/TREX2007745A/jo/texte [Accessed 27 Mar 2020].Search in Google Scholar
5. Regulation (EU) No 528/2012 of the European Parliament and of the council of 22 May 2012 concerning the making available on the market and use of biocidal products. Official Journal of the European Union dated June 27, 2012. Availiable from: https://eur-lex.europa.eu/legal-content/EN/TXT/PDF/?uri=CELEX:32012R0528 [Accessed 27 Mar 2020].Search in Google Scholar
6. European Chemicals Agency. List of active substances and suppliers in accordance with Article 95 of the Biocidal Products Regulation (BPR), as amended by Regulation (EU) No 334/2014 of 11 March 2014. Helsinki, Finland: European Chemicals Agency; 14 February 2020.Search in Google Scholar
7. Decree dated March 23, 2020: prescribing the organizational and functional measures of the health system necessary to respond to the epidemic of COVID-19 in the context of a health emergency; Official Journal of the French Republic n°n°0072 dated March 24, 2020. Available from: https://www.legifrance.gouv.fr/eli/arrete/2020/3/23/SSAX2007864A/jo/texte [Accessed 27 Mar 2020].Search in Google Scholar
8. Certificate of analysis and conformity of Ethanol 96% Cristalco; December 09, 2019.Search in Google Scholar
9. Ethanol 96%, Monograph 01/2015:1317 corrected 10.0. In: European Pharmacopoeia 10.0.Search in Google Scholar
10. ANSM. Good preparation practices. France: French National Agency for the Safety of Medicines and Health Products; December 03, 2007.Search in Google Scholar
© 2020 Elodie Di-Falco et al., published by De Gruyter, Berlin/Boston
This work is licensed under the Creative Commons Attribution 4.0 International License.
Articles in the same Issue
- Review Article
- Characteristics of wipe sampling methods for antineoplastic drugs in North America: comparison of six providers
- Research Articles
- Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit
- Physicochemical stability of compounded midazolam capsules over a one-year storage period
- Development and characterization of paracetamol medicated lollipops
- Measurement, analysis and prediction of amoxicillin oral dose stability from integrated molecular description approach and accelerated predictive stability (APS)
- Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/ml ursodeoxycholic acid for newborns
- Temperature impact on [68Ga]Ga-edotreotide for the shipping of radioactive material in shielded container
- Removal of bacterial growth inhibition of anticancer drugs by using complexation materials
- Microbiological stability tests with simulated broth preparations and integrity testing for sterile standard cytotoxic preparations
- Optimisation of the preparation of chemotherapy based on 5-fluorouracil by the use of peristaltic pumps
- Surface Contamination by Antineoplastic Drugs in Two Oncology Inpatient Units
- Short Communications
- How to validate radiopharmaceuticals management software?
- Do plasticized polyvinylchloride and polyurethane infusion sets promote infliximab adsorption?
- Opinon Paper
- Preparation of alcohol-based handrub in COVID-19 Alsatian cluster
- Guideline
- GERPAC Consensus Conference – Guidance on the Assignment of Microbiological Shelf-life for Hospital Pharmacy Aseptic Preparations
Articles in the same Issue
- Review Article
- Characteristics of wipe sampling methods for antineoplastic drugs in North America: comparison of six providers
- Research Articles
- Compatibility of injectable posaconazole with drugs commonly used in a hematology care unit
- Physicochemical stability of compounded midazolam capsules over a one-year storage period
- Development and characterization of paracetamol medicated lollipops
- Measurement, analysis and prediction of amoxicillin oral dose stability from integrated molecular description approach and accelerated predictive stability (APS)
- Development and validation of a new HPLC method for the analysis of a novel oral suspension formulation of 50 mg/ml ursodeoxycholic acid for newborns
- Temperature impact on [68Ga]Ga-edotreotide for the shipping of radioactive material in shielded container
- Removal of bacterial growth inhibition of anticancer drugs by using complexation materials
- Microbiological stability tests with simulated broth preparations and integrity testing for sterile standard cytotoxic preparations
- Optimisation of the preparation of chemotherapy based on 5-fluorouracil by the use of peristaltic pumps
- Surface Contamination by Antineoplastic Drugs in Two Oncology Inpatient Units
- Short Communications
- How to validate radiopharmaceuticals management software?
- Do plasticized polyvinylchloride and polyurethane infusion sets promote infliximab adsorption?
- Opinon Paper
- Preparation of alcohol-based handrub in COVID-19 Alsatian cluster
- Guideline
- GERPAC Consensus Conference – Guidance on the Assignment of Microbiological Shelf-life for Hospital Pharmacy Aseptic Preparations